Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Arango-Bravo EA"'
Autor:
Galicia-Carmona T; Department of Clinical Research, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Arango-Bravo EA; Department of Clinical Research, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Coronel-Martínez JA; Department of Clinical Research, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Cetina-Pérez L; Department of Clinical Research, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Vanoye-Carlo EG; Department of Surgical Oncology, Hospital Regional de Alta Especialidad de la Península de Yucatán, Yucatán, Mexico., Villalobos-Valencia R; Department of Medical Oncology, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico., García-Pacheco JA; NSR III Researcher assistant, Consejo Nacional de Humanidades, Ciencias y Tecnologías(CONACYT), Mexico City, Mexico., Cortés-Esteban P; Department of Medical Oncology, Centro Médico Nacional 20 de Noviembre, Mexico City, Mexico.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Aug 05; Vol. 14, pp. 1392639. Date of Electronic Publication: 2024 Aug 05 (Print Publication: 2024).
Autor:
Arango-Bravo EA; Medical Oncology Department, National Institute of Cancerology (INCan), Mexico City, Mexico.; Clinical Investigation Department, National Institute of Cancerology (INCan), Mexico City, Mexico., Galicia-Carmona T; Medical Oncology Department, National Institute of Cancerology (INCan), Mexico City, Mexico.; Clinical Investigation Department, National Institute of Cancerology (INCan), Mexico City, Mexico., Cetina-Pérez L; Medical Oncology Department, National Institute of Cancerology (INCan), Mexico City, Mexico.; Clinical Investigation Department, National Institute of Cancerology (INCan), Mexico City, Mexico., Flores-de la Torre CB; Oncology Department, Campeche State Oncology Center, Campeche, Mexico., Enríquez-Aceves MI; Oncology Department, Regional Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE) Hospital León, León de los Aldama, Guanajuato, Mexico., García-Pacheco JA; Sistema Nacional de Investigadores (SNI), National Council of Science and Technology (CONACYT), Mexico City, Mexico., Gómez-García EM; Oncology Department, Metepec Cancer Treatment Center, Metepec, Estado de México, Mexico.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Jun 28; Vol. 14, pp. 1386294. Date of Electronic Publication: 2024 Jun 28 (Print Publication: 2024).
Autor:
Alarcón-Barrios S; Programa de Maestría y Doctorado en Ciencias de la Salud, Universidad Nacional Autónoma de México, Mexico City, México; MICAELA Program, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Pain Clinic, Instituto Nacional de Cancerología, Mexico City, Mexico., Luvián-Morales J; MICAELA Program, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico., Castro-Eguiluz D; Consejo Nacional de Humanidades, Ciencia y Tecnología (CONAHCyT) Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico., Delgadillo-González M; MICAELA Program, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico., Lezcano-Velázquez BO; MICAELA Program, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Pain Clinic, Instituto Nacional de Cancerología, Mexico City, Mexico., Arango-Bravo EA; MICAELA Program, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico., Flores-Cisneros L; MICAELA Program, Instituto Nacional de Cancerología, Mexico City, Mexico., Aguiar Rosas S; MICAELA Program, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Pain Clinic, Instituto Nacional de Cancerología, Mexico City, Mexico., Cetina-Pérez L; MICAELA Program, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico; Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico. Electronic address: lucelycetina.incan@gmail.com.
Publikováno v:
Current problems in cancer [Curr Probl Cancer] 2024 Feb; Vol. 48, pp. 101041. Date of Electronic Publication: 2023 Nov 20.
Autor:
Cruz-Valdez A; Center for Population Health Research, Instituto Nacional de Salud Pública (INSP), Cuernavaca, Mexico., Palacio-Mejía LS; Consejo Nacional de Ciencia y Tecnología (CONACYT)-Instituto Nacional de Salud Pública (INSP), Cuernavaca, Mexico., Quezada-Sánchez AD; Center for Evaluation and Surveys Research, Instituto Nacional de Salud Pública (INSP), Cuernavaca, Mexico., Hernández-Ávila JE; Center for Evaluation and Surveys Research, Instituto Nacional de Salud Pública (INSP), Cuernavaca, Mexico., Galicia-Carmona T; Department of Clinical Research and Medical Oncology, Instituto Nacional de Cancerología (INCAN), Mexico City, Mexico., Cetina-Pérez LDC; Department of Clinical Research and Medical Oncology, Instituto Nacional de Cancerología (INCAN), Mexico City, Mexico., Arango-Bravo EA; Department of Clinical Research and Medical Oncology, Instituto Nacional de Cancerología (INCAN), Mexico City, Mexico., Isla-Ortiz D; Department of Oncology Gynecology, Instituto Nacional de Cancerología (INCAN), Mexico City, Mexico., Aranda-Flores CE; Oncology Department, Hospital General de México 'Eduardo Liceaga', Mexico City, Mexico., Uscanga-Sánchez SR; Gynecologist Oncologist of MAGNI Gineco-Obstetras S.C, Mexico City, Mexico., Madrid-Marina V; Chronic Infections and Cancer Division, Center for Research on Infectious Diseases, Instituto Nacional de Salud Pública (INSP), Cuernavaca, Mexico., Torres-Poveda K; Consejo Nacional de Ciencia y Tecnología (CONACYT)-Instituto Nacional de Salud Pública (INSP), Cuernavaca, Mexico.; Chronic Infections and Cancer Division, Center for Research on Infectious Diseases, Instituto Nacional de Salud Pública (INSP), Cuernavaca, Mexico.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Mar 09; Vol. 13, pp. 1008560. Date of Electronic Publication: 2023 Mar 09 (Print Publication: 2023).
Autor:
Arango-Bravo EA; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico, Mexico.; Integral program for the care of locally advanced and metastatic cervical cancer (MICAELA), Instituto Nacional de Cancerología, Mexico, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico, Mexico., Cetina-Pérez LDC; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico, Mexico.; Integral program for the care of locally advanced and metastatic cervical cancer (MICAELA), Instituto Nacional de Cancerología, Mexico, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico, Mexico.; Department of Oncology, Hospital Médica Sur, Mexico, Mexico., Galicia-Carmona T; Department of Clinical Research, Instituto Nacional de Cancerología, Mexico, Mexico.; Integral program for the care of locally advanced and metastatic cervical cancer (MICAELA), Instituto Nacional de Cancerología, Mexico, Mexico.; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico, Mexico., Castro-Eguiluz D; Department of Oncology, Hospital Médica Sur, Mexico, Mexico., Gallardo-Rincón D; Investigador por México CONACYT- Department of Clinical Research, Instituto Nacional de Cancerología, Mexico, Mexico., Cruz-Bautista I; Department of Metabolic Diseases Research, INCMNSZ, Mexico, Mexico., Duenas-Gonzalez A; Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Mexico, Mexico.; Division of Basic Research, Instituto Nacional de Cancerologia, Mexico, Mexico.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Nov 30; Vol. 12, pp. 1028291. Date of Electronic Publication: 2022 Nov 30 (Print Publication: 2022).